Postpandemic Influenza A/H1N1pdm09 is still Causing Severe Perinatal Complications
Hein Bogers, Dominique Bos, Sam Schoenmakers and Johannes J Duvekot
Erasmus MC, University Medical Centre Rotterdam, Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, University Medical Centre Rotterdam.
Received: October 6, 2014
Accepted: November 26, 2014
Mediterr J Hematol Infect Dis 2015, 7(1): e2015007, DOI 10.4084/MJHID.2015.007
This article is available on PDF format at:
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although influenza A/H1N1pdm09 is not causing a pandemic anymore, we recently observed two critically ill pregnant women infected by this virus. We present these cases to illustrate the possible severe complications of an – at that moment – seasonal influenza in pregnancy. We discuss the epidemiological differences between the pandemic and post pandemic phase and try to explain the high virulence of influenza A/H1N1pdm09 -infections in pregnancy by discussing insights in immunology during pregnancy. We conclude that although influenza A/H1N1pdm09 is in the post pandemic phase, infection by this influenza virus still needs to be considered in pregnant women with progressive respiratory dysfunction.
During the influenza A/H1N1pdm09 or swine flu pandemic, pregnant women appeared to be at increased risk for admission to an intensive care unit (ICU) because of complications of this viral disease. Although the World Health Organization has announced the disease to be postpandemic since August 2010, several mutations capable of causing severe illness have been isolated afterwards. After this pandemic phase, we admitted several pregnant women who were severely affected by influenza A/H1N1pdm09. In this article, we would like to draw attention to the possible severe complications of an - at that moment - seasonal influenza in pregnancy and try to explain its immunological origins. We hope to contribute to a greater awareness of influenza-related morbidity during pregnancy to prepare for future influenza pandemics.
The second patient is also a 28-year-old sub-Saharan nulliparous woman. Apart from a malaria infection more than ten years ago, she was in good health and accordingly had not received influenza vaccination. At a GA of 21 weeks, she reported with a cough and fever and was subsequently admitted. Chest radiograph revealed multiple infiltrations. PCR on a throat swab was only positive for influenza A/H1N1pdm09 and treatment with oseltamivir was started. Despite the treatment, her clinical condition worsened and mechanical ventilation was needed. Subsequently, foetal demise was diagnosed at a GA of 24 weeks, and labour was induced in an effort to improve her respiratory condition. The stillborn neonate had no visible anomalies. Although the PCR for influenza A/H1N1pdm09 became negative, she could not be weaned from mechanical ventilation. After three weeks, the steroid treatment was started under suspicion of a cryptogenic organising pneumonia, resulting in a dramatic improvement in respiratory function resulting in a full recovery.
Regarding perinatal morbidity, a large cohort study by Pierce et al. showed this was up to six-fold increased in children born to influenza A/H1N1pdm09 -infected women, as compared to uninfected women. This was primarily caused by an increased stillbirth rate (3 % v. 1 %, p = 0.001). Preterm birth was more observed as well, and those women also had higher odds of being admitted to the ICU (54% v. 12%, p<0.001).
Our patients were immigrants. In the only study on this subject, the incidence of influenza infection in the native and immigrant population was investigated during the pandemic in Spain by Esteban-Vasallo et al. A trend was seen towards more severe influenza cases in immigrant women of childbearing age compared to native women (21.3% v.12.3%, p = 0.06).
Pregnancy as risk factor. There are studies comparing severity of disease in pregnant versus non-pregnant mice. Chan et al. showed that A/H1N1pdm09 demonstrated in pregnant mice infection with influenza damage mainly confined to the lungs, with no signs of extrapulmonary dissemination. The pregnant mice exhibited more severe pneumonia, damaged lung epithelium and higher mortality as compared with the non-pregnant mice. The lung damage was associated with an increased pro-inflammatory and pro-Th-2 cytokine profile, whereas the Th-1 (antiviral) immune response was similar to significant lower in the pregnant group. Other groups also reported a slower innate immune response to infection with influenza A/H1N1pdm09 in pregnant mice and inhibition of cytotoxic natural killer cells, which would allow a higher replication rate of the virus. A subsequent increased pulmonary infiltration by macrophages and neutrophils with high production of nitric oxide damages the pulmonary epithelium,[8,9] which already has a slower level of regeneration due to infection. This can lead to increased pulmonary permeability, thus compromising the respiratory capacity further. Moreover, with ongoing pregnancy a more decreased pulmonary capacity can be observed. As GA progresses, the enlarging uterus causes an increase in abdominal pressure, resulting in a decreased chest wall compliance and diaphragmatic elevation. Furthermore, lower levels of respiratory maternal immunoglobulins G (IgGs) after the initial contact with influenza A/H1N1pdm09 are reported. It appears that during pregnancy maternal IgG-antibodies become trapped in the placenta to protect the developing foetus, while making the IgG-antibodies unavailable for the maternal immune defence.[8,9] IgG-antibodies play a major role in the lower respiratory tract, further contributing to the fulminant course of influenza A/H1N1pdm09 -infection in pregnancy.
Postpandemic influenza A/H1N1pdm09. Our two patients were admitted after the Dutch pandemic. So far, no studies described the features of this post pandemic wave in pregnant patients. There have been few reports describing the differences between the pandemic and post pandemic influenza A/H1N1pdm09 -infection in non-pregnant patients. These reports all mention a marked increase in severity during the post pandemic phase,[12-15] which could be due to mutations of the virus. The rate ratio for hospitalisation was 2.6 (95% CI 2.3-2.9) and patients appeared to be older during the post pandemic (median 35 years) than during the pandemic phase (median 20 years) (p<0.0001). Time from onset of illness to administration of antiviral therapy and length of stay was also longer, and need for mechanical ventilation and ICU admission were significantly higher during the post pandemic period.
Future pandemics. Investigating influenza pandemics might help to prepare for future pandemics, but influenza will remain a threat to mankind due to continuing mutations of the influenza A-specific antigens. Although influenza A/H1N1pdm09 is in its post pandemic phase, severe illness remains possible. In all pregnant women with respiratory problems, infection with influenza A/H1N1pdm09 always needs to be considered. Early diagnosis and treatment may reduce the risk of severe illness. Vaccination is still highly recommended even after the pandemic influenza A/H1N1pdm09 phase.
None of the authors has any interest to disclose. No financial support was given to prepare this manuscript.
- York I, Donis RO. The 2009 pandemic influenza
virus: where did it come from, where is it now, and where is it going?
Curr Top Microbiol Immunol 2013;370: 241-57. http://dx.doi.org/10.1007/82_2012_221
- Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010;31: 676-82. http://dx.doi.org/10.1086/653204
- Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011;205: 10-8. http://dx.doi.org/10.1016/j.ajog.2010.12.033
- Maravi-Poma E, Martin-Loeches I, Regidor E, Laplaza C, Cambra K, Aldunate S, Guerrero JE, Loza-Vazquez A, Arnau E, Almirall J, Lorente L, Arenzana A, Magret M, Reig Valero R, Marquez E, Gonzalez N, Bermejo-Martin JF, Rello J, Grupo Espanol de Trabajo de Gripe Grave A. Severe 2009 A/H1N1v influenza in pregnant women in Spain. Crit Care Med 2011;39: 945-51. http://dx.doi.org/10.1097/CCM.0b013e318208ee12
- Ellington SR, Hartman LK, Acosta M, Martinez-Romo M, Rubinson L, Jamieson DJ, Louie J. Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California. Am J Obstet Gynecol 2011;204: S21-30. http://dx.doi.org/10.1016/j.ajog.2011.02.038
- Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M, on behalf of U. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011;342: d3214. http://dx.doi.org/10.1136/bmj.d3214
- Esteban-Vasallo MD, Dominguez-Berjon MF, Aerny-Perreten N, Astray-Mochales J, Martin-Martinez F, Genova-Maleras R. Pandemic influenza A (H1N1) 2009 in Madrid, Spain: incidence and characteristics in immigrant and native population. Eur J Public Health 2011.
- Chan KH, Zhang AJ, To KK, Chan CC, Poon VK, Guo K, Ng F, Zhang QW, Leung VH, Cheung AN, Lau CC, Woo PC, Tse H, Wu W, Chen H, Zheng BJ, Yuen KY. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS One 2010;5: e13757.
- Marcelin G, Aldridge JR, Duan S, Ghoneim HE, Rehg J, Marjuki H, Boon AC, McCullers JA, Webby RJ. Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice. J Virol 2011;85: 11208-19. http://dx.doi.org/10.1128/JVI.00654-11
- Poole JA, Claman HN. Immunology of pregnancy. Implications for the mother. Clin Rev Allergy Immunol 2004;26: 161-70. http://dx.doi.org/10.1385/CRIAI:26:3:161
- Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997;102: 2-9; discussion 25-6.
- Bolotin S, Pebody R, White PJ, McMenamin J, Perera L, Nguyen-Van-Tam JS, Barlow T, Watson JM, for the UKSISSSG. A New Sentinel Surveillance System for Severe Influenza in England Shows a Shift in Age Distribution of Hospitalised Cases in the Post-Pandemic Period. PLoS One 2012;7: e30279.
- Martin-Loeches I, Diaz E, Vidaur L, Torres A, Laborda C, Granada R, Bonastre J, Martin M, Insausti J, Arenzana A, Guerrero JE, Navarrete I, Bermejo-Martin J, Suarez D, Rodriguez A, the HNSRCWg. Pandemic and post-pandemic Influenza A (H1N1) infection in critically ill patients. Crit Care 2011;15: R286. http://dx.doi.org/10.1186/cc10573
- Viasus D, Cordero E, Rodriguez-Bano J, Oteo JA, Fernandez-Navarro A, Ortega L, Gracia-Ahufinger I, Farinas MC, Garcia-Almodovar E, Payeras A, Pano-Pardo JR, Munez-Rubio E, Carratala J, Novel Influenza ASGotSNfRiID. Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect 2012;18: E55-62. http://dx.doi.org/10.1111/j.1469-0691.2011.03753.x
- Lehners N, Geis S, Eisenbach C, Neben K, Schnitzler P. Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany. Emerg Infect Dis 2013;19: 748-55. http://dx.doi.org/10.3201/eid1905.130034
- Pano-Pardo JR, Rodriguez-Bano J, Martinez-Sanchez N, Viasus D, Farinas MC, Leyes M, Lopez-Medrano F, Pachon J, Torre-Cisneros J, Oteo JA, Pumarola T, Garcia-Gasalla M, Ortega L, Segura F, Carratala J, Novel Influenza ASGotSNfRiID. Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy. Antivir Ther 2012;17: 719-28. http://dx.doi.org/10.3851/IMP2019
- Rasmussen SA, Jamieson DJ. 2009 H1N1 influenza and pregnancy--5 years later. N Engl J Med 2014;371: 1373-5. http://dx.doi.org/10.1056/NEJMp1403496